Innoviva (INVA) Cash from Operations (QoQ) (2010 - 2025)
Innoviva (INVA) Cash from Operations (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Innoviva | 1.61 Bn | 1.01 Bn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 223.14% |
| Jun 30, 2025 | -9.35% |
| Sep 30, 2024 | 196.10% |
| Jun 30, 2024 | 18.01% |
| Sep 30, 2023 | 182.35% |
| Jun 30, 2023 | 48.66% |
| Sep 30, 2022 | 143.98% |
| Jun 30, 2022 | -19.44% |
| Sep 30, 2021 | 213.70% |
| Jun 30, 2021 | 0.60% |
| Mar 31, 2021 | -1.38% |
| Dec 31, 2020 | 14.38% |
| Sep 30, 2020 | -6.56% |
| Jun 30, 2020 | 8.59% |
| Mar 31, 2020 | 9.83% |
| Dec 31, 2019 | 16.56% |
| Sep 30, 2019 | 1.60% |
| Jun 30, 2019 | -26.30% |
| Mar 31, 2019 | 24.08% |
| Dec 31, 2018 | 2.76% |